Bachour Tarek, Bennett Katie
Molecular Pathology, Dept of Laboratory Sciences and Primary Care, Texas Tech University Health Sciences Center at Lubbock, TX.
J Assoc Genet Technol. 2011;37(1):21-8.
Breast cancer is the most common form of cancer in women. Despite extensive study, the etiology of breast cancer remains ambiguous. A group of genetic modifiers known as microRNAs (miRNAs) are emerging onto the scene of breast cancer research. MicroRNAs are small, non-coding RNAs that are involved in the regulation of key cellular processes such as proliferation, differentiation, and apoptosis. They can interfere directly with the translation and stability of a targeted gene transcript and cause a disturbance in the cell physiology. The dysregulation of both oncogenes and tumor suppressor genes by aberrant miRNA production can result in the progression to breast cancer. This review provides a discussion of the nature of miRNAs, explains the role of miRNAs in the etiology and progression of breast cancer, and discusses their potentials as therapeutic molecules and diagnostic markers.
乳腺癌是女性中最常见的癌症形式。尽管进行了广泛研究,但乳腺癌的病因仍不明确。一组被称为微小RNA(miRNA)的基因修饰因子正出现在乳腺癌研究领域。微小RNA是小的非编码RNA,参与细胞增殖、分化和凋亡等关键细胞过程的调控。它们可直接干扰靶基因转录本的翻译和稳定性,并导致细胞生理紊乱。异常miRNA产生导致的癌基因和肿瘤抑制基因失调可导致乳腺癌进展。本综述讨论了miRNA的性质,解释了miRNA在乳腺癌病因和进展中的作用,并讨论了它们作为治疗分子和诊断标志物的潜力。